Genomics

Dataset Information

0

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial


ABSTRACT: We report a first-in-human trial evaluating safety and immunogenicity of a recombinant BCG, AERAS-422, over-expressing TB antigens Ag85A, Ag85B, and Rv3407 and expressing mutant perfringolysin. Interpretation: The unexpected development of VZV in two of eight healthy adult vaccine recipients resulted in discontinuation of AERAS-422 vaccine development. Immunological and transcriptomal data identified correlations with the development of TB immunity and VZV that require further investigation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE87186 | GEO | 2016/09/22

SECONDARY ACCESSION(S): PRJNA343804

REPOSITORIES: GEO

Similar Datasets

2021-12-06 | GSE156422 | GEO
| PRJNA501541 | ENA
| PRJNA557735 | ENA
| PRJNA581046 | ENA
2019-05-15 | PXD006141 | Pride
2023-02-08 | GSE222349 | GEO
2016-11-08 | GSE88575 | GEO
2023-02-08 | GSE199811 | GEO
| PRJNA712244 | ENA